[1] Wieman TJ: Principles of management: the diabetic foot. The American Journal of Surgery 2005, 190: 295-299.

[2] Boulton AJM: Pressure and the diabetic foot: clinical science and offloading techniques. The American Journal of Surgery 2004, 187: 17S-24S.

[3] Edmonds M: The use of antibiotics in the diabetic foot. The American Journal of Surgery 2004, 187: 25S-28S.

[4] Carson SN, Pankovich A, Travis E, To D, Rodriguez A: Healing chronic infected foot wounds with human fibroblast-derived dermal substitute and silver dressings. Health Management Publications, Inc 2005, 17 (10): 282-289.

[5] Maki D, et al: Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Annals of Internal Medicine 1997, 127: 257-266

[6] Matrix metalloproteinases in normal and impaired wound healing: a potential use of nanocrystalline silver. Wound 2001, 13 (3) supplemental.

[7] Falcone AE, Spadaro JA: Inhibitory effects of electrically activated silver material on cutaneous wound bacteria. Plastic and Reconstructive Surgery 1986, 77 (3): 455-458.

[8] Deitch E, et al: Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity. The Journal of Trauma 1987, 27 (3): 301-304.

[9] Berger TJ, et al: Electrically generated silver ions: quantitative effects on bacterial and mammalian cells. Antimicrobial Agents and Chemotherapy 1976, 9 (2): 357-358.

[10] Bacterin Laboratory Report 2000.

[11] R.O.Becker patent #5,814,094 and 4,528,265.

1. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., et al. (2002). Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II)

Journal of the American Medical Association. 288:49-57.

2. Hulley, S., Furberg, C., Barrett-Connor, E., Cauley, J., Grady, D., Haskell, W., et al. (2002). Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II) Journal Of The American Medical Association. 288:58-64.

3. Fugate, S., & Church, C. (2004). Nonestrogen treatment modalities for vasomotor symptoms associated with menopause. The Annals of Pharmacotherapy, 38:1482–1499. Retrieved May 14, 2006 from http://www.theannals.com

4. Fraser, D., Thoen, J., Selvaag, A., Djoseland, O., Forre, O., & Kjeldsen-Kragh, J. (2001). Preliminary study of circadian serum cortisol concentrations in response to a 72-hour fast in rheumatoid arthritis patients not previously treated with corticosteroids. Clinical Rheumatology; 20(2):85-7. Retrieved January 10, 2005 from www.ncbi.nlm.nih.gov

5. Wilson, J., Foster, D., Kronenberg, H., & Larsen, R. (1998a). Williams Textbook of Endocrinology, 9th Edition, Section 6, Chapter 20; p 942.

6. Michalsen, A., Schneider, S., Rodenbeck, A., Ludtke, R., Huether, G., & Dobos, G. (2003). The short-term effects of fasting on the neuroendocrine system in patients with chronic pain syndromes. Nutritional Neuroscience; Feb;6(1):11-8. Retrieved January 12, 2005 from www.ncbi.nlm.nih.gov

7. Kurzer, M., & Calloway, D. (1986). Effects of energy deprivation on sex hormone patterns in healthy menstruating women. Department of Nutritional Sciences, UC Berkeley, CA. American Physiological Society, pp. E483-E488.

8. Pedersen, A., Bartholomew, M., Dolence, L., Aijadir, L., Netteburg, K., & Loyd, T. (1991). Menstrual differences due to vegetarian and non-vegetarian diets. American Journal of Clinical Nutrition; 53:879-85. Retrieved July 24, 2006 from http://www.sjcn.org

9. Berrino, F., Bellat, C., Secreto, G., Camerini, E., Pala, V., Panico, S. et al. (2001). Reducing bioavailable sex hormones through a comprehensive change in diet: The Diet and Androgens (DIANA) Randomized Trial. Cancer Epidemiology, BiMarkers & Prevention. Vol 10, 25-33

10. Atkinson, C., Frankenfeld, C., & Lampe, J. (2005). Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Experimental Biology and Medicine 230:155-170

11. Krebs, E., Ensrud, K., MacDonald, R., & Wilt, T. (2004). Phytoestrogens for treatment of menopausal symptoms: A systematic review. Obstetrics & Gynecology; 104:824-836. Retrieved May 14, 2006 from http://www.greenjournal.org

12. Baber, R.J., Templeman, C., & Morton, T. (1999). Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric; 2: 85-92[Medline]. Retrieved February 18, 2006 from www.ncbi.nlm.nih.gov

13. Knight, D., Howes, J., & Eden, J. (1999). The effect of promensil, an isoflavone extract, on menopausal symptoms. Climacteric; 2: 79-84 Medline. Retrieved July 23, 2006 from http://www.ncbi.nlm.nih.gov/entrez/query

14. Arjmandi, B., Khalil, D., Smith, B., Lucas, E., Juma, S., Payton, M., et al. (2003). Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 3 1048-1054. Retrieved April 1, 2006 from http://jcem.endojournals.org/cgi/content/abstract/88/3/1048

15. Davis, S.R. (2001). Editorial. Phytoestrogen, Therapy for menopausal symptoms? British Medical Journal; 323:354-355, 18 August. Retrieved January 7, 2005 from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1120966

16. Kotecha, N., & Lockwood, B. (2005). Soy – relieving the symptoms of menopause and fighting osteoporosis. The Pharmaceutical Journal, Vol 275; 483-487. Retrieved April 1, 2006 from http://www.pjonline.com

17. Epstein, S. (1991). Potential public health hazards of biosynthetic milk hormones. International Journal of Health Services;21(2):373. Retrieved May 28, 2006 from http://www.ncbi.nlm.nih.gov/entrez/query

18. Galbraith, H. (2002). Hormones in international meat production: biological, sociological and consumer issues. Nutritional Research Reviews, 15, 293-314. Retrieved February 19, 2006 from http://www.ingentaconnect.com/content/cabi/nrr/2002/00000015/00000002/art00006

19. Reichman, M., Judd, J., Longcope, C., Schatzkin, A., Clevidence, B., Nair, P., et al (1993) Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. Journal Of The National Cancer Institute, Vol. 85, No. 9 7222-727. Retrieved May 16, 2006 from http://jncicancerspectrum.oxfordjournals.org

20. Gill, J. (2000). The Effects of Moderate Alcohol Consumption on Female Hormone Levels and Reproductive Function. Dept of Occupational Therapy, Queen Margaret University College, Edinburgh EH8 6HF, UK. Retrieved May 16, 2006 from http://alcalc.oxfordjournals.org

21. Mendelson, J., Mello, N., & Ellingboe, J. (1997). Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males. American Society for Pharmacology and Experimental Therapeutics, Vol 202, Issue 3, pp. 676-682. Retrieved May 16, 2006 from http://jpet.aspetjournals.org

22. Baron, J., Comi, R., Cryns, V., Brinck-Johnsen, T., & Mercer, N. (1995). The effect of cigarette smoking on adrenal cortical hormones. American Society for Pharmacology and Experimental Therapeutics, Vol 272, Issue 1, pp 1, Edition 1951-155. Retrieved May 16, 2006 from http://jpet.aspetjournals.org

23. Lovallo, W., Pincomb, G., Sung, B., Passey, R., Sausen, K., & Wilson, M. (1989). Caffeine may potentiate adrenocortical stress responses in hypertension-prone men. Journal of American Heart Association, Hypertension, pp. 170-176

Downloaded on March 4, 2006 from http://www.hyper.ahajournals.org